Our Science – Klebanoff Website
Christopher A. Klebanoff, M.D.
Our lab is interested in cellular differentiation and maturation of components of both the innate and adoptive immune systems, with a specific emphasis on how controlling immunologic differentiation can impact adoptive T cell immunotherapies. Our overall goal is to develop promising new immunotherapies for the treatment of cancer built upon a mechanism-based understanding of CD8+ T cell and conventional dendritic cell functions discovered in our laboratory.
This page was last updated on 4/30/2014.